Listed

Nutex Health Inc.

NUTXNasdaqCIK 1479681IndustrialsFiscal year ends Dec 31

Reports and events: 226 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Nutex Health Inc., Reports and events
FiledFormWhat it isAccession number
2021-11-2416:06 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-21-000563
2021-11-1514:24 ET10-QQuarterly reportPeriod 2021-09-300001607062-21-000537
2021-10-2116:58 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-21-000440
2021-10-0117:19 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001607062-21-000375
2021-08-1613:13 ET10-QQuarterly reportPeriod 2021-06-300001607062-21-000272
2021-07-2210:21 ET8-K5.02 Departure or appointment of officers or directors0001607062-21-000235
2021-05-2417:25 ET10-QQuarterly reportPeriod 2021-03-310001607062-21-000142
2021-05-2417:43 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-21-000138
2021-05-2112:43 ET8-K/A9.01 Financial statements and exhibits0001607062-21-000136
2021-04-1317:12 ET8-K5.02 Departure or appointment of officers or directors0001607062-21-000081
2021-04-0519:58 ET10-KAnnual reportPeriod 2020-12-310001607062-21-000074
2021-03-0513:03 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001607062-21-000041
2021-03-0215:34 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-21-000039
2020-11-1613:30 ET10-QQuarterly reportPeriod 2020-09-300001607062-20-000329
2020-09-2308:24 ET10-Q/AQuarterly report, amendedPeriod 2020-06-300001607062-20-000289
2020-09-0817:18 ET8-K4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits0001607062-20-000259
2020-08-2421:06 ET10-Q/AQuarterly report, amendedPeriod 2020-06-300001607062-20-000246
2020-08-1917:21 ET10-QQuarterly reportPeriod 2020-06-300001607062-20-000238
2020-07-1515:08 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001607062-20-000197
2020-07-0216:34 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001607062-20-000193
2020-06-2912:10 ET10-QQuarterly reportPeriod 2020-03-310001607062-20-000189
2020-06-0315:35 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-20-000142
2020-05-1914:20 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001607062-20-000137
2020-05-1509:39 ET8-K8.01 Other events0001607062-20-000127
2020-05-1417:15 ET10-KAnnual reportPeriod 2019-12-310001607062-20-000125
2020-04-1317:10 ET8-K8.01 Other events0001607062-20-000098
2019-11-2208:36 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001607062-19-000459
2019-11-1911:48 ET10-QQuarterly reportPeriod 2019-09-300001607062-19-000457
2019-11-1216:33 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-19-000431
2019-11-0418:28 ET8-K2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-19-000421
2019-08-2012:47 ET10-Q/AQuarterly report, amendedPeriod 2019-06-300001607062-19-000346
2019-08-2018:02 ET10-QQuarterly reportPeriod 2019-06-300001607062-19-000343
2019-08-0911:55 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001607062-19-000314
2019-06-2712:54 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001607062-19-000284
2019-05-2014:35 ET10-QQuarterly reportPeriod 2019-03-310001607062-19-000235
2019-04-1714:09 ET10-K/AAnnual report, amendedPeriod 2018-12-310001607062-19-000163
2019-04-1616:46 ET10-KAnnual reportPeriod 2018-12-310001607062-19-000159
2018-11-2012:35 ET10-Q/AQuarterly report, amendedPeriod 2018-09-300001607062-18-000432
2018-11-2017:40 ET10-QQuarterly reportPeriod 2018-09-300001607062-18-000430
2018-10-2914:15 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001607062-18-000371
2018-09-1214:23 ET8-K/A7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001607062-18-000273
2018-09-1214:20 ET8-K/A3.03 Change to security holders’ rights; 5.01 Change in control; 9.01 Financial statements and exhibits0001607062-18-000271
2018-08-1414:54 ET10-QQuarterly reportPeriod 2018-06-300001607062-18-000246
2018-08-0616:04 ET8-K3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001607062-18-000241
2018-06-1916:36 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001607062-18-000207
2018-05-1514:55 ET10-QQuarterly reportPeriod 2018-03-310001607062-18-000172
2018-04-1712:18 ET10-KAnnual reportPeriod 2017-12-310001607062-18-000127
2017-11-2014:22 ET10-QQuarterly reportPeriod 2017-09-300001607062-17-000400
2017-08-1814:20 ET10-QQuarterly reportPeriod 2017-06-300001607062-17-000278
2017-07-2613:57 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001551163-17-000129

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.